3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
11
Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)
1
NSCLC
1
Melanoma
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
Carboplatin
15
Etoposide
13
atezolizumab
9
Topotecan
8
durvalumab
7
Specimen Handling
7
PM 01183
6
Cisplatin
5
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
Injections
3
Biopsy
3
berzosertib
2
Nivolumab
2
Fulvestrant
2
Drug Therapy
2
AMG 757
2
tremelimumab
1
trastuzumab deruxtecan
1
toripalimab
1
tazemetostat
1
palbociclib
1
olaparib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
cabozantinib
1
budigalimab
1
arginine decarboxylase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
osimertinib
×
30 days
×
Clear all
No trials found.